Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Keytruda Top Seller for 4 Months Running: Encise
December 7, 2020
- Ex-Janssen Exec Rami Suzuki to Lead Ferring Japan
December 7, 2020
- Kobayashi Kako Recalls Itraconazole over Hypnotic Contamination; Side Effects Confirmed
December 7, 2020
- 26 Japan Drug Makers Barely Avoid Revenue Decline in H1 FY2020 Despite Price Cuts, COVID-19: Tally
December 4, 2020
- Sandoz to Discontinue Filgrastim Biosimilars; Late Market Entry a Factor
December 4, 2020
- 2 More Soft Bag Products Recalled Over Flawed Testing at Kyowa CritiCare
December 3, 2020
- Telomelysin Triplet Enters Japan PI for HCC: Oncolys
December 3, 2020
- Janssen Files SC Injection of Darzalex/Vorhyaluronidase Alfa for AL Amyloidosis in Japan
December 3, 2020
- Crysvita Now Available for Self-Injection in Japan: Kyowa Kirin
December 2, 2020
- Hirosaki University to Test StemRIM’s Redasemtide for Knee Osteoarthritis
December 2, 2020
- Sosei Licenses CGRP Antagonists to Biohaven
December 2, 2020
- Japan’s 1st Therapeutic App Now Available: CureApp
December 2, 2020
- Takeda Closes Sale of 18 Non-Core Meds to Celltrion in Asia-Pacific
December 2, 2020
- 1st Patient Enrolled in Adoptive Trial by Amgen, Takeda, UCB: COVID R&D Alliance
December 2, 2020
- Sanofi Japan to Sharpen Focus on Priority Pipelines as It Eyes Turnaround after 2022: President
December 1, 2020
- AstraZeneca Japan Exec Vows Thorough Safety Evaluation for COVID-19 Vaccine
December 1, 2020
- Demand for Nesp Biosimilars Spiking as Hospitals Turn to Cheaper Meds in Dialysis Care, Shipment Control Triggered
December 1, 2020
- Abbott Japan Taps Managing Exec Officer Takechi as New President
December 1, 2020
- Keytruda-Chemo Combo Filed for 1st Line Esophageal Cancer in Japan
December 1, 2020
- Chugai Now Takes Nissan Chemical to Court over Edirol Patent, Seeks Damages from Sawai, Nichi-Iko Too
November 30, 2020
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…